Epitech Group - Glialia 400 mg + 40 mg PEALUT® PEA Лютеолин

Suppie Report

Epitech Group

Glialia 400 mg + 40 mg PEALUT® PEA Лютеолин

B grade
75/100
SUPPIE SCORE
65/100
EFFICACY
High
SAFETY
70/100
CLEANLINESS

What Does Glialia 400 mg + 40 mg PEALUT® PEA Лютеолин Do?

Glialia delivers 400 mg palmitoylethanolamide and 40 mg luteolin per tablet in a co-ultramicronized PEALUT® form intended to target neuroinflammation via mast cell and glial modulation.
What is the typical recommended duration and daily intake for Glialia tablets based on clinical use?
Are there any specific populations or conditions where PEA + luteolin combinations have shown the strongest evidence?
Is Glialia 400 mg + 40 mg PEALUT® PEA Лютеолин a good fit for my goals?
Chat with Suppie

What Are the Benefits of Glialia 400 mg + 40 mg PEALUT® PEA Лютеолин?

Based on proven scientific research

Neuroinflammation modulationModerate
Neuropathic pain reliefModerate
Cognitive support in neuroinflammatory statesMild

Good For:

What Are the Side Effects of Epitech Group Glialia 400 mg + 40 mg PEALUT® PEA Лютеолин?

Always consult your health practitioner if in doubt.

RiskLow Risk

Overview

Palmitoylethanolamide 400 mg and luteolin 40 mg per tablet are generally well-tolerated with no major side effects reported in studies at these levels.
Product is gluten-free but contains titanium dioxide (E171) as a colorant, which some regulatory bodies have restricted in food uses.
Recommended intake of 2 tablets daily (800 mg PEA + 80 mg luteolin) for 3-6 months under medical supervision for neuroinflammatory conditions.
Not recommended during pregnancy; keep out of reach of children under 3 years.
Classified variably as food supplement or food for special medical purposes depending on market; use should align with labeled indications.
No significant drug interactions commonly reported for PEA or luteolin at supplemental doses, but consult physician if on medications for CNS conditions.

Potential Side Effects

Negative Interactions

Allergens

None listed (gluten-free)

Inactive Ingredients

Microcrystalline cellulose
Low Risk
Magnesium stearate
Low Risk
Croscarmellose sodium
Low Risk
Colloidal anhydrous silica
Low Risk
Talc
Medium Risk
Titanium dioxide (e171)
Medium Risk
Yellow iron oxide (e172)
Low Risk
Polyethylene glycol (macrogol e1521)
Low Risk
Polyvinylpyrrolidone
Low Risk
Polyvinyl alcohol
Low Risk
Vegetable polysorbate
Low Risk

What Are the Ingredients in Epitech Group Glialia 400 mg + 40 mg PEALUT® PEA Лютеолин?

Palmitoylethanolamide (PEA) in co-ultramicronized PEALUT® form
400 mg
Luteolin in co-ultramicronized PEALUT® form
40 mg
Microcrystalline cellulose
Magnesium stearate
Croscarmellose sodium
Colloidal anhydrous silica
Talc
Titanium dioxide (E171)
Yellow iron oxide (E172)
Polyethylene glycol (Macrogol E1521)
Polyvinylpyrrolidone
Polyvinyl alcohol
Vegetable polysorbate

Scan the bottle in your cupboard

Same graded report you just read — on any label, in about 10 seconds.

Download on the App Store

Dosage & Bioavailability

How the active doses and forms in Glialia 400 mg + 40 mg PEALUT® PEA Лютеолин compare to the research.

Palmitoylethanolamide (in co-ultramicronized PEALUT®) — 400 mg per tablet; typical studied doses range 300-1200 mg/day, with ultramicronization improving bioavailability over.
Luteolin (in co-ultramicronized PEALUT®) — 40 mg per tablet; dose aligns with combination studies but individual luteolin bioavailability data are limited.

Frequently Asked Questions

Common questions about Epitech Group Glialia 400 mg + 40 mg PEALUT® PEA Лютеолин